S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/BVF Partners/Q4 2023

BVF Partners

Period: Q4 2023 Β· Filed: 2024-02-14
View on SEC EDGAR β†—
AUM
$4.00B
Total portfolio value
Positions
70
Reported securities
Top Holding
MLTX
32.9% $1.31B
QoQ Changes
+7 / -6
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2024-02-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
MLTXMOONLAKE IMMUNOTHERAPEUTICS$1.31B32.87%$59.55$18.95-68.2%
32.9%
RVMDREVOLUTION MEDICINES INC$171.5M4.29%$28.23$189.24+570.4%
4.3%
AXSMAXSOME THERAPEUTICS INC$157.7M3.95%$77.06$244.31+217.0%
4.0%
PTGXPROTAGONIST THERAPEUTICS INC$131.7M3.30%$23.42$131.62+462.0%
3.3%
KYMRKYMERA THERAPEUTICS INC$131.4M3.29%$25.35$113.51+347.8%
3.3%
MIRMMIRUM PHARMACEUTICALS INC$129.0M3.23%$30.02$125.59+318.4%
3.2%
OLMAOLEMA PHARMACEUTICALS INC$128.2M3.21%$13.73$12.64-7.9%
3.2%
IONSIONIS PHARMACEUTICALS INC$122.9M3.07%$52.87$81.80+54.7%
3.1%
KURAKURA ONCOLOGY INC$106.0M2.65%$15.36$11.10-27.7%
2.6%
FDMT4D MOLECULAR THERAPEUTICS IN$81.2M2.03%$21.25$13.00-38.8%
2.0%
LKFTGALAPAGOS NV$77.8M1.95%$41.34$30.39-26.5%
1.9%
MRUSMERUS N V$75.7M1.89%β€”β€”
1.9%
RPTXREPARE THERAPEUTICS INC$75.4M1.89%β€”β€”
1.9%
ACIUAC IMMUNE SA$72.9M1.82%$4.69$2.51-46.5%
1.8%
CNTACENTESSA PHARMACEUTICALS PLC$69.8M1.75%$8.03$40.50+404.4%
1.8%
XOMAXOMA CORP DEL$67.2M1.68%$20.89$43.00+105.8%
1.7%
IDYAIDEAYA BIOSCIENCES INC$61.5M1.54%$35.22$37.65+6.9%
1.5%
ZYMEZYMEWORKS INC$61.0M1.53%$10.38$26.31+153.5%
1.5%
GHRSGH RESEARCH PLC$60.3M1.51%$5.35$27.01+404.9%
1.5%
EPIXESSA PHARMA INC$57.7M1.45%β€”β€”
1.4%
JANXJANUX THERAPEUTICS INC$49.1M1.23%$11.02$15.54+41.0%
1.2%
THRDTHIRD HARMONIC BIO INC$47.9M1.20%β€”β€”
1.2%
ETNB89BIO INC$45.2M1.13%β€”β€”
1.1%
RLAYRELAY THERAPEUTICS INC$43.7M1.09%$11.85$18.65+57.4%
1.1%
XENEXENON PHARMACEUTICALS INC$41.0M1.03%$44.91$60.96+35.7%
1.0%
SNDXSYNDAX PHARMACEUTICALS INC$40.5M1.01%$21.86$21.82-0.2%
1.0%
TYRATYRA BIOSCIENCES INC$37.9M0.95%$14.04$30.62+118.1%
0.9%
LXRXLEXICON PHARMACEUTICALS INC$37.4M0.94%$1.59$2.32+45.9%
0.9%
GPCRSTRUCTURE THERAPEUTICS INC$33.1M0.83%$40.39$53.45+32.3%
0.8%
CGEMCULLINAN ONCOLOGY INC$32.6M0.82%$10.59$17.63+66.5%
0.8%

Quarter-on-Quarter Activity

Q4 2023 vs. Q3 2023

New Positions (7)

TickerIssuerNotionalSince Filing
SNDXSYNDAX PHARMACEUTICALS INC$40.5M-0.2%
ANNXANNEXON INC$31.8M
ENGNENGENE HOLDINGS INC$20.8M
SYRESPYRE THERAPEUTICS INC$14.8M
VTGNVISTAGEN THERAPEUTICS INC$10.3M
SABSSAB BIOTHERAPEUTICS INC$6.3M
ENGNWENGENE HOLDINGS INC$0.8M

Exited Positions (6)

TickerIssuerNotional
PNTPOINT BIOPHARMA GLOBAL INC$70.5M
ACRSACLARIS THERAPEUTICS INC$48.4M
REPLREPLIMUNE GROUP INC$36.7M
JSPRXXXXJASPER THERAPEUTICS INC$6.9M
IMUXIMMUNIC INC$1.7M
BNOXBIONOMICS LIMITED$0.1M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
ETNB89BIO INC$16.7M+119.2%
ACIUAC IMMUNE SA$51.7M+96.2%-46.5%
RLAYRELAY THERAPEUTICS INC$23.8M+67.8%+57.4%
IKNAIKENA ONCOLOGY INC$-4.3M+50.5%
RVMDREVOLUTION MEDICINES INC$61.3M+50.2%+570.4%
RPTXREPARE THERAPEUTICS INC$-24.7M+24.6%
LXRXLEXICON PHARMACEUTICALS INC$15.6M+22.2%+45.9%
GHRSGH RESEARCH PLC$-32.9M+12.1%+404.9%

Trimmed (7)

TickerIssuerNotionalShares Ξ”Since Filing
IDYAIDEAYA BIOSCIENCES INC$-81.0M-67.3%+6.9%
GPCRSTRUCTURE THERAPEUTICS INC$-55.1M-53.5%+32.3%
XENEXENON PHARMACEUTICALS INC$-21.4M-51.3%+35.7%
IONSIONIS PHARMACEUTICALS INC$-58.8M-39.4%+54.7%
UNCYUNICYCIVE THERAPEUTICS INC$-1.1M-37.9%
AXSMAXSOME THERAPEUTICS INC$8.7M-7.0%+217.0%
CNTACENTESSA PHARMACEUTICALS PLC$10.9M-3.6%+404.4%
← Back to Hedge Funds